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Abstract 
 
The xanthine oxidase (XO)-inhibitory activity of aqueous and organic extracts of 27 
selected species belonging in five genera (Fallopia, Oxyria, Persicaria, Polygonum and 
Rumex) of the family Polygonaceae occurring in the Carpathian Basin were tested in 
vitro. From different plant parts (aerial parts, leaves, flowers, fruits and roots) a total of 
196 extracts were prepared by subsequent extraction with methanol and hot H2O, and 
solvent–solvent partition of the MeOH extract yielding n-hexane, chloroform and 50% 
MeOH subextracts. It was found that the chloroform subextracts and/or the remaining 
50% MeOH extracts of Fallopia species (F. bohemica, F. japonica and F. 
sachalinensis), Rumex species (R. acetosa, R. acetosella, R. alpinus, R. conglomeratus, 
R. crispus, R. hydrolapathus, R. pulcher, R. stenophyllus, R. thyrsiflorus, R. obtusifolius 
subsp. subalpinus, R. patientia) and Polygonum bistorta, P. hydropiper P. lapathifolium  
and P. viviparum demonstrated the highest XO-inhibitory activity (> 85% inhibition) at 
400 µg/mL. The IC50 values of the active extracts were also determined. On the basis of 
the results, these plants, and especially P. hydropiper and R. acetosella, are considered 
worthy of activity-guided phytochemical investigations. 
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INTRODUCTION 
 
Xanthine oxidase (XO), an enzyme present in significant concentrations in the 
gastrointestinal tract and liver, is responsible for the metabolism of hypoxanthine and 
xanthine to uric acid in the purine catabolic pathway, yielding superoxide radicals. XO 
is an important biological source of O2
•-
 and has been reported in various pathological 
processes; it plays a crucial role in various forms of ischaemic and other types of tissue 
and vascular injuries, inflammatory diseases, stroke, diabetes mellitus, rheumatic 
disease, liver disorders, renal failure and chronic heart failure (Parks et al., 1983; 
Harrison, 2002). Moreover, excessive levels of uric acid in the blood, i.e. 
hyperuricaemia, cause gout. XO inhibitors are able to hinder the synthesis of uric acid 
in the organism and, as anti-inflammatory agents, can alleviate the symptoms of 
inflammatory associated diseases (Liu et al., 2008). In clinical practice, only allopurinol 
is used to inhibit the enzyme, in the treatment and prevention of gout, but it can cause a 
number of adverse side-effects, such as allergic and hypersensitivity reactions, 
gastrointestinal distress, nephropathy, skin rash and enhancement of 6-mercaptopurine 
toxicity (Pacher et al., 2006). The development of new hypouricaemic agents with 
greater effectiveness and a better safety profile is therefore highly desirable. 
In recent years, a number of research groups have commenced explorations of 
potencial XO inhibitors from a wide variety of traditional folk medicines. Numerous 
studies have dealt with investigations of the XO-inhibitory activities of plant extracts 
used in certain countries for the treatment of hyperuricaemia, and especially gout (Owen 
et al., 1999; Kong et al., 2000). Among the natural compounds that have been tested, 
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the flavonoids have attracted considerable attention, and structure-activity relationship 
studies have been performed (Cos et al., 1998). 
As a continuation of our screening programme relating to plants and bioactive 
natural compounds in the flora of the Carpathian Basin (Réthy et al., 2007; Csupor-
Löffler et al., 2009; Lajter et al., 2013, Ványolós et al., 2014), the present work 
describes for the first time a systematic in vitro XO-inhibitory assay of extracts prepared 
from 27 species belonging in the Fallopia, Rumex, Polygonum, Persicaria and Oxyria 
genera of the Polygonaceae family occurring in the Carpathian Basin. 
Polygonaceae species are distributed worldwide; this family comprises 
approximately 1200 species in 50 genera. The largest genera are Calligonum, 
Coccoloba, Persicaria Polygonum, Rheum and Rumex. There are 32 species that are 
native or naturalized to Hungary and 45 in the Carpathian Basin (Jávorka and Csapody 
1991). Numerous species are traditionally used as vegetables (e.g. Rheum rhabarbarum 
and Rumex acetosa) and in folk medicine. Rhubarb (Rheum palmatum) is a well-known 
medicinal plant of the family; it has been used as a laxative for centuries. P. cuspidatum 
has been utilized in traditional Asian medicine as a diuretic agent (Mazid et al., 2009). 
The leaves of R. nepalensis have found use in traditional medicine for the treatment of  
injury caused by stinging nettles and against colic and syphilic ulcers (Gautam et al., 
2010). Its roots are used to cure dysentery. Fallopia species are traditionally utilized in 
Asia for the treatment of inflammation, hepatitis, osteomyelitis, gallstone and skin burn 
(Hromádková et al., 2010). Polygonum cognatum, Rheum ribes and Rumex acetosella 
have been applied for the treatment of urinary inflammation and as diuretic agents in 
Turkish ethnomedicine (Cakilcioglu et al., 2010). 
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The H2O extract of P. cuspidatum rhizome has been reported to display 
noteworthy XO-inhibitory activity (IC50 = 38 μg/mL). In analogous tests, neither the 
MeOH nor the H2O extract of P. aviculare (whole plant) or R. palmatum (rhizome) 
exerted any activity (Kong et al., 2000). 
The most characteristic compounds identified in the species of the Polygonaceae 
family are phenolic compounds (e.g. anthraquinones, flavonoids, naphthalenes, 
stilbenes and tannins), terpenoids and polysaccharides (Hegnauer, 1990; Demirezer et 
al., 2001). In some cases, drimane sesqui- and norsesquiterpenoids and sulfated 
flavonoids have also been isolated from Polygonum species (Fukuyama et al., 1982; 
Yagi et al., 1994). 
Polygonaceae species are rich sources of bioactive constituents which contribute 
to a wide range of medicinal properties. Stilbene derivatives (e.g. resveratrol and piceid) 
with antimicrobial and antioxidant activities have been isolated from Polygonaceae 
species (Shan et al., 2008). Flavonoids and chalcones of P. hydropiper exhibit strong 
antioxidant effects, and play an important role against pathologic processes that give 
rise to oxidative stress, such as arteriosclerosis or cancer (Yagi et al., 1994). The widely 
used medicinal plant R. palmatum contains anthranoids (e.g. emodin, aloe-emodin and 
physcion) as main active constituents. Their pharmacological activities have been 
investigated in many assays. Aloe-emodin has been reported to induce the apoptosis of 
hepatocellular carcinoma cells (Jeon et al., 2012). Emodin has been investigated for its 
antidiabetic and antitumour activity (Xue et al., 2010; Hsu et al., 2012), and for its 
lipid-lowering and neuroprotective effects in rat cortical neurons (Liu et al., 2010; 
Mishra et al., 2014). Quercetin and its derivatives, isolated from many plants of this 
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family, are used widely as standards in XO-inhibitory assays because of their strong 
activities (Lee et al., 2008). 
 
MATERIALS AND METHODS 
 
Plant materials. Plants were collected in several regions of the Carpathian Basin 
(Croatia, Hungary and Romania) in the flowering period between June and September 
2010. Botanical identifications were performed by Gusztáv Jakab (Institute of 
Environmental Sciences, Faculty of Water and Environmental Management, Szent 
István University, H-5540 Szarvas, Hungary) and Lajos Balogh (Natural History 
Collection, Savaria Museum, H-9700 Szombathely, Hungary). Voucher specimens for 
each plant (Nos 777-803) have been deposited at the Herbarium of the Department of 
Pharmacognosy, University of Szeged, Szeged, Hungary. 
 
Preparation of the extracts. Extracts were prepared from 10 g of air-dried, powdered 
plant material with 100 mL of MeOH with the use of an ultrasonic bath (3 × 15 min). 
After filtration, the solutions were evaporated to dryness under reduced pressure. The 
residues were dissolved in 50 mL of 50% aqueous MeOH and were subjected to 
solvent–solvent partition between n-hexane (3 × 50 mL) (extracts A) and CHCl3 (3 × 50 
mL) (extracts B); and the residual 50% MeOH extracts were named extracts C. After 
the extraction with MeOH, the residual plant materials were dried and extracted with 30 
mL of boiling H2O for 15 min. The filtered extracts were freeze-dried, affording 
extracts D. The yields (w/w) of the extracts are shown in Table 1. 
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Xanthine oxidase assay. The method is based on a modified protocol of Sigma, a 
continuous spectrophotometric rate determination: the absorbance of XO-induced uric 
acid production from xanthine was measured at 290 nm for 3 min in a 96-well plate, 
using the plate reader FluoSTAR OPTIMA (BMG LABTECH). The XO-inhibitory 
effect was determined via the decreased production of uric acid. Reagents: 50 mM 
potassium phosphate buffer, pH 7.5 with 1 M KOH, 0.15 mM xanthine solution (pH 
7.5), and XO solution (0.2 units/mL). XO, isolated from bovine milk (lyophilized 
powder) and xanthine powder were purchased from Sigma-Aldrich Co. The different 
plant extracts (12 mg/mL) were prepared in DMSO. For enzyme-activity control, the 
final reaction mixture comprised of 100 μL of xanthine, 150 μL of buffer and 50 μL of 
XO in a 300 μL well. The reaction mixture for inhibition was made with 100 μL of 
xanthine, 140 μL of buffer, 10 μL of sample and 50 μL of XO. Allopurinol served as 
positive control. Extracts were added in appropriate volumes so that the final 
concentration of DMSO in the assay did not exceed 3.3% of the total volume. All the 
experiments were conducted in triplicate. The reaction was initiated by the automatic 
addition of 0.050 mL of XO solution to a final concentration of 0.006 units/mL. The 
IC50 values were calculated by analysing the inhibition (%) of each concentration, by 
using GraphPad Prism 5.04 software (GraphPad Software Inc.) with non-linear 
regression.  
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RESULTS AND DISCUSSION 
 
In the course of our screening study, the XO-inhibitory activities of 27 species of the 
Polygonaceae family [Fallopia (3), Oxyria (1), Persicaria (2), Polygonum (8) and 
Rumex (13)] occurring in the Carpathian Basin, were evaluated. The results of the 
assays are listed in Table 1. The extracts were prepared with methanol from selected 
plant organs and solvent–solvent partition was performed with n-hexane (A) and CHCl3 
(B). The remaining aqueous MeOH (C) and the H2O (D) extracts (altogether 196 
extracts) were also tested. Although there was no generally accepted threshold for 
efficacy in our experiment, XO-inhibitory effects of < 10% were considered irrelevant, 
and are therefore not presented in Table 1. At 400 μg/mL, a total of 69 extracts 
demonstrated substantial XO-inhibitory activity (≥50% inhibition), while 32 among 
them exhibited a >80% inhibitory effect. For these extracts, IC50 values were also 
determined (Table 1). 
Among the fractions with different polarities, fractions B (containing CHCl3-
soluble lipophilic constituents) and some fractions C (aqueous MeOH extracts) proved 
to be active. The n-hexane and residual aqueous extracts (fractions A and D, 
respectively) demonstrated pronounced XO-inhibitory effects (>50% inhibition) in only 
a few cases [F. japonica roots (A), P. arenarium whole plant (A), P. bistorta roots (A) 
and R. crispus herbs (D)]. Moreover, the extracts B and/or C of aerial parts and roots of 
different plants were equally active. 
33 CHCl3-soluble subfractions (16.8% of the total) and 28 aqueous MeOH 
subextracts (14.3%) exerted XO-inhibitory activity at 400 μg/mL. Among the active 
subextracts, 48% of the CHCl3-soluble fractions and 55% of the aqueous MeOH 
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extracts possessed an inhibition rate > 80%. Under the conditions of the assay, the IC50 
of allopurinol, used clinically as a XO-inhibitory drug, was 1.019 ± 0.04 μg/mL. 
As concerns the Fallopia species, all of the investigated plants (F. bohemica, F. 
japonica and F. sachalinensis) displayed significant XO inhibitory activities. These 
results were in agreement with data published by Kong et al. (in 2000) on F. japonica 
(syn. P. cuspidatum; IC50 = 38 μg/mL). This plant has been used in traditional Chinese 
medicine for the treatment of gout. 
As regards the Polygonum species, the roots of P. bistorta (90.7% C) and P. 
hydropiper (100.3% B and 96.6% C), the aerial parts of P. lapathifolium (101.7% C) 
and the whole plant of P. viviparum (80.9% B) proved to exert marked efficacy against 
XO enzyme. The XO inhibitory activity of five fractions with different polarity of 
methanolic extract of P. hydropiper was investigated by Hashim et al., and it was 
observed that the n-butanol and ethyl acetate fractions showed marked inhibitory effect 
with IC50s = 28.72 and 165.25 μg/mL (Hashim et al., 2013). Previous phytochemical 
investigations have revealed the presence of flavonoids (e.g. quercetin, quercitrin, rutin, 
etc.) and sulfated flavonoids (isorhamnetin-3,7-disulfate) in P. hydropiper (syn. 
Persicaria hydropiper) (Yagi et al., 1994); it can be supposed that such compounds are 
responsible for the XO inhibitory activity. 
A comparison of the measured activities with the ethnomedicinal uses of the 
plants led to the conclusion that the present screening results for several Rumex species 
are in accordance with the traditional uses of the plants against gout, inflammatory 
diseases and chronic heart failure. Especially the CHCl3 extracts (B) of the whole plant 
of R. acetosella (IC50 = 19.3 μg/mL), the CHCl3 extract (B) prepared from the flowers 
and fruits of R. alpinus (IC50 = 23.4 μg/mL), the herb extract (B) of R. conglomeratus 
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(IC50 = 23.4 μg/mL), the root extract (C) of R. hydrolapathum (IC50 = 25.4 μg/mL), and 
the flowers and fruits extracts of R. patientia (B) and R. stenophyllus (C) (IC50 = 27.6 
and 27.3 μg/mL) exhibited high activity against XO. Some of them are applied 
traditionally as an anti-inflammatory, diuretic and anticancer agent (Rao et al., 2011). 
In view of the pronounced XO-inhibitory activity of the appreciable number of 
investigated species, they are worthy of further investigations, including bioassay-
guided isolation and identification of the active substances. Earlier publications on the 
highly active R. acetosella indicated the presence of phenolic compounds and its 
antioxidant capacity, but its XO-inhibitory activity has not been investigated previously 
(Özen, 2010). However, the ability of inhibiting XO is strongly connected with the 
antioxidant capacity, since reactive oxygen species are produced during the formation of 
uric acid in the presence of XO. Hence, the results of the investigations of the radical-
scavenging activity or the reducing power of the plants suggest the XO-inhibition 
potency of the plants and their compounds (Maksimovic et al., 2011). 
In summary, the present paper reports for the first time a systematic 
comprehensive study on the XO-inhibitory activity of Polygonaceae species native to 
the Carpathian-basin, including 27 species of Fallopia, Oxyria, Persicaria, Polygonum 
and Rumex genera. The in vitro screen has provided important preliminary data 
promoting the selection of Polygonaceae species (native to the Carpathian Basin) and 
their different extracts with potential anti-hyperuricaemic properties for future work. 
These species, and especially P. hydropiper, R. acetosella, R. alpinus, R. 
conglomeratus, R. hydrolapathum, R. patientia and R. stenophyllus, are promising 
candidates for further activity-guided fractionation in the search for new active XO-
inhibitory natural compounds.  
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Table 1. The yield and XO inhibitory effects of the prepared extracts 
 
Species Plant parts Solvent 
Yield  
(w/w%) 
Xanthine oxidase enzyme inhibition 
400 µg/ml (% ± SD) IC50 (µg/ml ± SD) 
Fallopia × 
bohemica (Chrtek 
et Chrtková) J. P. 
Bailey 
leaves A 6.6 39.22 ± 7.91 . 
 B 0.9 79.91 ± 7.82 . 
 C 7.4 35.29 ± 3.89 . 
 D 4.6 17.69 ± 5.80 . 
roots A 1.3 24.23 ± 9.45 . 
 C 19.2 86.59 ± 5.25 91.29 ± 1.28 
 D 4.3 21.90 ± 5.88 . 
Fallopia japonica 
(Houtt.) Ronse 
Decr. 
leaves B 2.2 53.17 ± 6.34 . 
 C 7.3 45.31 ± 1.09 . 
 D 5.6 11.92 ± 2.10 . 
roots A 1.1 65.67 ± 14.02 . 
 B 4.7 90.22 ± 9.57 112.37 ± 9.24 
 C 19.2 92.39 ± 3.30 55.71 ± 6.98 
 D 2.1 37.27 ± 7.55 . 
Fallopia 
sachalinensis (F. 
Schmidt) Ronse 
Decr. 
leaves B 2.5 104.37 ± 30.23 65.49 ± 14.19 
 C 13.2 75.43 ± 15.19 . 
 D 4.3 23.90 ± 2.42 . 
roots A 2.0 25.71 ± 4.91 . 
 B 2.5 101.14 ± 38.51 147.93 ± 9.40 
 C 12.2 56.49 ± 16.23 . 
Oxyria digyna (L.) 
Hill. 
whole plant B 3.0 36.01 ± 8.08 . 
 C 9.8 56.61 ± 4.06 . 
Persicaria 
amphibia f. 
terrestris (L.) Gray 
whole plant A 2.0 26.15 ± 13.06 . 
 B 0.6 41.31 ± 17.14 . 
 C 2.92 43.19 ± 21.13 . 
Persicaria 
maculosa Gray 
herbs A 2.6 39.38 ± 2.50 . 
 B 3.3 92.98 ± 7.94 68.83 ± 5.75 
roots B 8.6 69.12 ± 7.98 . 
 C 5.9 10.58 ± 3.41 . 
Polygonum 
arenarium W. et K. 
whole plant A 7.7 63.80 ± 2.11 . 
 B 1.67 24.05 ± 12.30 . 
 C 8.3 52.03 ± 6.59 . 
Polygonum 
aviculare L. 
whole plant B 2.2 61.61 ± 0.74 . 
 C 9.1 39.15 ± 5.09 . 
Polygonum 
bellardii All. 
whole plant A 1.5 22.64 ± 7.52 . 
 B 4.1 65.49 ± 11.22 . 
 C 12.2 54.01 ± 4.40 . 
 D 4.9 22.52 ± 7.20 . 
Polygonum bistorta 
L. 
leaves B 8.7 48.37 ± 14.85 . 
  C 12.0 33.63 ± 5.85 . 
  D 1.8 28.51 ± 1.71 . 
roots A 1.7 78.61 ± 11.82 . 
  B 0.6 66.13 ± 6.86 . 
  C 26.8 90.72 ± 2.81 33.40 ± 0.87 
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Species Plant parts Solvent 
Yield  
(w/w%) 
Xanthine oxidase enzyme inhibition 
400 µg/ml (% ± SD) IC50 (µg/ml ± SD) 
  D 9.0 28.38 ± 1.90 . 
Polygonum 
hydropiper L. 
herbs A 4.0 12.77 ± 1.11 . 
 B 4.1 53.46 ± 3.43 . 
 C 8.3 43.25 ± 8.85 . 
 D 5.3 11.44 ± 4.22 . 
roots B 1.1 100.25 ± 32.19 85.49 ± 11.17 
 C 4.7 96.56 ± 4.90 16.41 ± 3.36 
 D 1.4 12.53 ± 3.63 . 
Polygonum 
lapathifolium L. 
herbs A 4.1 20.55 ± 7.52 . 
 B 1.1 78.77 ± 10.57 . 
 C 9.5 101.70 ± 5.80 74.86 ± 8.33 
roots B 1.5 31.97 ± 11.02 . 
 C 15.2 54.40 ± 9.62 . 
 D 4.0 12.36 ± 2.48 . 
Polygonum 
rurivagum Jord. 
ex. Boreau 
whole plant A 1.5 24.22 ± 4.77 . 
pll B 3.5 49.50 ± 10.52 . 
 C 11.6 46.46 ± 4.37 . 
 D 4.9 19.27 ± 3.20 . 
Polygonum 
viviparum L. 
whole plant A 6.2 25.66 ± 5.87 . 
 B 2.3 80.90 ± 11.46 42.33 ± 2.42 
 C 8.9 48.15 ± 10.67 . 
Rumex acetosa L. 
 
herbs A 5.0 28.83 ± 16.51 . 
 B 3.4 90.29 ± 9.84 91.08 ± 9.78 
 C 8.2 37.96 ± 8.39 . 
roots A 1.8 40.88 ± 10.87 . 
 B 3.3 54.08 ± 2.39 . 
Rumex acetosella 
L. 
whole plant A 2.9 21.45 ± 4.02 . 
 B 2.9 83.29 ± 2.01 19.32 ± 3.11 
 C 3.9 61.03 ± 2.15 . 
 D 3.6 33.13 ± 1.75 . 
Rumex alpinus L. flowers/  A 1.9 40.69 ± 11.94 . 
fruits B 2.4 93.95 ± 10.01 23.40 ± 3.04 
 C 12.6 63.04 ± 7.29 . 
leaves A 3.7 18.05 ± 13.21 . 
 B 2.2 96.98 ± 2.82 49.34 ± 6.73 
 C 13.4 60.85 ± 3.87 . 
 D 4.3 12.26 ± 1.77 . 
roots A 2.4 47.86 ± 0.78  
 B 3.9 90.89 ± 13.22 146.60 ± 25.76 
 C 21.7 49.75 ± 5.64  
 D 3.4 51.53 ± 6.45  
Rumex aquaticus 
L. 
leaves A 3.3 30.68 ± 15.61  
 B 1.4 55.75 ± 5.78  
 C 6.3 19.28 ± 9.77  
roots A 1.4 24.71 ± 9.55  
 B 2.1 63.89 ± 22.86  
 C 18.4 77.91 ± 15.72  
18 
Species Plant parts Solvent 
Yield  
(w/w%) 
Xanthine oxidase enzyme inhibition 
400 µg/ml (% ± SD) IC50 (µg/ml ± SD) 
Rumex 
conglomeratus 
Murr. 
herbs A 3.3 35.88 ± 14.89  
 B 6.3 98.92 ± 4.92 23.38 ± 3.97 
 C 10.6 80.86 ± 15.94 51.49 ± 9.41 
 D 1.5 31.38 ± 3.34  
Rumex crispus L.  herbs A 2.0 15.03 ± 3.17  
 B 3.1 68.48 ± 18.62  
 C 7.8 81.72 ± 0.01 37.34 ± 3.07 
 D 3.7 73.41 ± 6.85  
roots A 2.4 19.12 ± 2.59  
 C 16.6 35.85 ± 1.52  
 D 1.7 47.04 ± 4.59  
Rumex 
hydrolapathum 
Huds. 
leaves A 2.1 28.08 ± 5.39  
 B 2.9 57.25 ± 11.99  
 C 14.5 94.23 ± 9.84 73.83 ± 7.09 
 D 2.5 49.89 ± 9.90  
roots C 25.0 90.93 ± 13.68 25.40 ± 2.23 
 D 0.7 55.34 ± 5.16  
Rumex obtusifolius 
subsp. obtusifolius 
L. 
herbs A 7.5 30.57 ± 0.91  
 B 3.8 46.74 ± 2.32  
 C 7.1 61.93 ± 7.10  
 D 6.6 28.76 ± 4.05  
roots B 3.3 52.95 ± 3.18  
 C 14.3 70.36 ± 7.66  
 D 2.3 43.47 ± 2.84  
Rumex obtusifolius 
subsp. subalpinus 
(Schur) Rech. fil. 
herbs  A 3.8 51.99 ± 21.73  
 B 1.2 91.52 ± 6.29 112.90 ± 7.80 
 C 6.2 92.11 ± 7.68 33.62 ± 5.60 
roots A 0.9 14.97 ± 4.79  
 B 1.4 95.86 ± 6.88 134.00 ± 23.82 
 C 31.7 42.48 ± 6.16  
 D 7.9 19.52 ± 6.78  
Rumex patientia L. flowers A 3.9 12.42 ± 1.78  
 B 4.0 112.20 ± 5.04 27.63 ± 3.29 
 C 6.0 104.24 ± 1.50 18.87 ± 1.23 
 D 0.7 17.37 ± 0.52  
roots A 2.4 42.57 ± 5.70  
 B 3.0 87.33 ± 11.35 97.61 ± 8.25 
 C 22.4 110.04 ± 7.06 60.02 ± 11.67 
 D 2.7 13.93 ± 1.55  
Rumex pulcher L. whole plant A 3.5 44.04 ± 4.16  
 B 1.6 75.43 ± 9.23  
 C 8.8 96.24 ± 1.56 51.72 ± 4.80 
Rumex scutatus L. whole plant B 3.4 49.30 ± 16.96  
 C 7.0 36.27 ± 6.17  
 D 4.7 10.09 ± 6.63  
Rumex 
stenophyllus 
flowers/  A 3.7 35.71 ± 0.45  
fruits B 5.5 21.02 ± 10.61  
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Species Plant parts Solvent 
Yield  
(w/w%) 
Xanthine oxidase enzyme inhibition 
400 µg/ml (% ± SD) IC50 (µg/ml ± SD) 
Ledeb.  C 12.6 99.94 ± 8.56 27.28 ± 0.41 
 D 1.8 31.93± 5.44  
leaves A 2.0 30.46 ± 4.03  
 B 0.6 77.52 ± 15.69  
 C 8.8 42.69 ± 2.21  
 D 2.9 12.77 ± 2.48  
roots B 5.4 46.00 ± 3.91  
 C 17.3 76.07 ± 3.41  
 D 2.8 41.60 ± 9.64  
Rumex thyrsiflorus 
Fingerh. 
herbs A 3.6 35.80 ± 28.81  
 B 2.6 56.53 ± 11.95  
 C 7.1 99.67 ± 5.77 78.45 ± 18.81 
 D 4.6 49.26 ± 8.48  
roots C 6.3 97.79 ± 7.25 39.25 ± 4.11 
 D 1.2 11.87 ± 1.46  
 
 
